11 March 2002
Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.Urszula Trafikowska, Anna Trafikowska, Andrzej Adamowicz, Bronisław Zachara, Jacek Manitius
Med Sci Monit 2002; 8(3): CR202-205 :: ID: 420901
BACKGROUND: The kidney accumulates the highest level of selenium (Se) inthe organism and is the major source of plasma glutathione peroxidase (GSH-Px). Se, as an integral partof the active site of GSH-Px, plays an important role in protecting cell membranes from oxidative damage.Decreased blood Se levels and GSH-Px activity are common in chronic renal failure (CRF) patients. Ourstudy was an effort to evaluate the effect of erythropoietin (EPO) therapy and Se supplementation forCRF patients undergoing regular hemodialysis (HD) on blood Se, red cell glutathione (GSH), and bloodlipid peroxidation product levels, and on blood activity levels of GSH-Px and blood superoxide dismutase(SOD). MATERIAL/METHODS: Our subjects were divided into three groups: I - CRF patients on regular HDand EPO, II - HD patients receiving EPO and Se, and III - healthy controls. Se levels, SOD and GSH-Pxactivities were measured spectrofluorometrically, the GSH level by Beutler's colorimetric method, andlipid peroxidation products using TBARS. RESULTS: EPO therapy with Se supplementation significantly increasedwhole blood and plasma Se in HD patients, and raised red cell GSH-Px activity, but plasma GSH-Px activity,plasma superoxide dismutase, and plasma and red cell TBARS did not respond to Se supplementation. EPOalone showed no effect on these parameters. CONCLUSIONS: Treatment with EPO and supplementation withSe significantly increased the element concentration in whole blood and plasma, and GSH-Px activity inred cells. Plasma GSH-Px activity did not respond to Se.
Keywords: Adolescent, Dietary Supplements, Erythropoietin, Glutathione Peroxidase, Kidney Failure, Chronic, Renal Dialysis, Research Support, Non-U.S. Gov, Selenium, Spectrometry, Fluorescence, Time Factors, Uremia
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952